Kyverna Therapeutics, Inc. (KYTX)

Kyverna Therapeutics, Inc. (KYTX) is a healthcare company (biotechnology) based in the United States. The share price is $4.70, down 1.26% on the day, which values the company at $297.14M. Price as of 18 Nov 2026, 09:47 UTC, from Yahoo Finance.

Key facts

Share price
$4.70−1.26% today
Market value
$297.14M
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Kyverna Therapeutics, Inc. in more detail

KYTX trades at -1.5× next year's expected earnings.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Thin interest cover.

Kyverna Therapeutics, Inc. (KYTX): questions and answers

What is Kyverna Therapeutics, Inc.'s market cap?

Kyverna Therapeutics, Inc. is valued at $297.14M at a share price of $4.70.

Does KYTX pay a dividend?

Kyverna Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Kyverna Therapeutics, Inc. (KYTX) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/KYTX

Underlying data: Yahoo Finance; company filings with the SEC.